Abiopharma

OTC Markets Group Welcomes Capitan Silver Corp. to OTCQX

Sportradar Expands Partnership with Hard Rock Bet, Adding Official Data from the PGA TOUR and Ultimate Fighting Championship

Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

Buda Juice Reports Full Year Fiscal 2025 Financial Results

NMG Files 2025 Financial Reports and Advances Phase‑2 Matawinie Mine Toward Construction

Upbound Group, Inc. Declares Quarterly Cash Dividend of $0.39 for the Second Quarter of 2026

NMG dépose ses rapports financiers de 2025 et poursuit le développement de la mine Matawinie de la phase 2 en vue de la construction

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team

Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders